XPHYF News and Press, XPhyto Therapeutics Corp From 04/15/21

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) , a bioscience technology accelerator, is set to launch a solution for improving detection of the virus responsible for the worldwide pandemic. The company recently announced European regulatory approval of its point-of-care SARS-CoV...

Women have contributed greatly to the psychedelics industry , accomplishing incredible research and work in the field, despite being maligned in serious ways for just being involved. Given that International Women’s Month has just ended, the timing seems ideal to shine a spotlight on...

A cannabis activist from Iowa is  suing the state’s governor  based on the argument that the state’s Department of Health has taken too long to request for the federal exemption of the state’s medical marijuana program from the DEA as stipulated in a legislatio...

Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner XPhyto received approval for the test kit last month from European regulators with oversight o...

VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment oppo...

CE Mark received for in vitro diagnostic (IVD) test for the detection of SARS-CoV-2 Rapid results with ease of use - single 20-minute PCR cycle plus 5-minute detection process High sensitivity - 104.73 c/PCR limit of detection with 95% confidence interval High specificity - z...

LOS ANGELES, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of ...

VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the "Company"), and its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"), are pleased to announce successful EN ISO 13485 certification for th...

An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 09, 2021 (GLOBE NEWSWIRE) -- Last month we introduced our readership to XPhyto Therapeutics Corp. (XPHYF). At such time, we mentioned that the Company is also involved in psychedelics and that we would dive in...

VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), is pleased to announce that the Company has completed a corporate rebranding and launched a new website which can be viewed at www.xphyto.com . The rebrand...